Clinical Trial: Prospective Feasibility Pilot Study Evaluating the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC) at Diagnosis and Disease Progression

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07007325) titled 'Prospective Feasibility Pilot Study Evaluating the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC) at Diagnosis and Disease Progression' on March 20.

Brief Summary: [68Ga]Ga-PentixaFor PET-CT will be performed in patients with Small cell lung cancer (SCLC) to confirm the targeting of CXCR4 by [68Ga]Ga-PentixaFor

Study Start Date: Sept. 15, 2025

Study Type: INTERVENTIONAL

Condition: Small Cell Lung Carcinoma (SCLC)

Intervention: DRUG: [68Ga]Ga-PentixaFor

[68Ga]Ga-PentixaFor PET-CT

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Institut Cancerologie de l'Ouest

Disclaimer: Curated...